Dynamics of methylated cell-free DNA in the urine of non-small cell lung cancer patients

Dynamics of methylated cell-free DNA in the urine of non-small cell lung cancer patients

High levels of methylated DNA in urine represent an emerging biomarker for non-small cell lung cancer (NSCLC) detection and are the subject of ongoing research. This study aimed to investigate the circadian variation of urinary cell-free DNA (cfDNA) abundance and methylation levels of cancer-associa...

Full description

Bibliographic Details
Main Authors: Sander Bach, Birgit M.M. Wever, Mark A. van de Wiel, Joris D. Veltman, Sayed M.S. Hashemi, Geert Kazemier, Idris Bahce, Renske D.M. Steenbergen
Format: Article
Language:English
Published: Taylor & Francis Group 2022-10-01
Series:Epigenetics
Subjects:
biological variation
biomarker
cancer detection
cfdna
circadian variation
non-small cell lung cancer
urine
dna methylation
Online Access:http://dx.doi.org/10.1080/15592294.2021.1982511

Similar Items

Similar Items